Three years later, FDA expanded the label to include the broader treatment of primary hyperlipidemia with bempedoic ... If you have a molecule you would like us to consider, please send us a message.

Hyperlipidemia is a powerful and extremely common risk factor for cardiovascular disease (CVD) among all racial/ethnic groups. However, there are certain racial/ethnic differences in the ...